In April 2026, the FDA published a formal proposal in the Federal Register to remove semaglutide, tirzepatide, and liraglutide from the 503B outsourcing bulks list, with a public comment period open through June 2026
Bayside predicted on December 16 that tirzepatide is 80% likely to come off shortage this week, which proved true, and asserted, I think there is a 50% chance the same thing happens with semaglutide, either this week or next. After the tirzepatide decision, they raised their estimate to 80%
Why Researchers Choose PSPeptides US Manufactured: Every batch is synthesized in FDA-registered US facilities with strict QC oversight and documentation
And dont forget to drink 810 glasses of water daily staying hydrated helps the fiber do its job and keeps constipation at bay
Storage and Handling Protocols Proper storage of peptides glp3 is crucial for maintaining compound stability and research validity